PetVivo Holdings Inc · OTC:PETV
PetVivo — Investor Presentation (April 2016)
35 slides from PetVivo's investor presentation, April 2016

Slide 1: PetVivo Holdings, Inc. Corporate Presentation
! ! ! ! ! PetVivo!Holdings,!Inc.!! Corporate!Presenta7on! ! April!2016!

Slide 2: Forward-Looking Statements
!!!!!!FORWARD(LOOKING!STATEMENTS! This!presenta7on!and!the!accompanying!oral!commentary!contains!forwardClooking!statements!within!the!meaning! of! the! federal! securi7es! laws,! which! statements! are! subject! to! substan7al! risks! and! uncertain7es! that! could! cause! actual!results!to!differ!m

Slide 3: Investment Highlights
Investment!Highlights!! • Commercial!stage!pet!therapeu7cs!company! • Ready!to!launch!commercializa7on!of!a!par7culate!device!for!the!$2B! osteoarthri7s!market!in!companion!animals!with!funding! • Kush™!product!offers!significant!benefits!for!the!management!of!pain!over! NSAIDs!which!are!the!exis7ng!st

Slide 4: Seasoned Leadership Team
Seasoned!Leadership!Team! John!Lai!CoCfounder,!CEO!&!Chairman.!Mr.!Lai!has!over!30!years!of!senior! opera7ons!and!financial!experience!and!has!served!as!CEO!at!Rovvr,!Inc.!&!Genesis! Capital!Group,!Inc.,!President!at!Viper!Powersports,!Inc.!and!CFO!at!Buyitnow.com.! Mr.!Lai!has!extensive!experience!i

Slide 5: PetVivo Overview
PetVivo!Overview!! • GelCDel!Founded!in!1999!by!Dr.!David!Masters!and!headquartered!in!St.!Paul,!MN! • Completed!a!reverse!merger!on!3/11/14!with!Technologies!Scan!Corp!to!become! a!public!company!and!subsequently!renamed!PetVivo! • Technology!originally!developed!by!Dr.!Masters!at!Mayo!Clinic!and!t

Slide 6: Companion Animal & Veterinarian Market Overview
!Companion!Animal!&!Veterinarian!Market!Overview! U.S.!Pet!Owners!Spend*!! • Large!and!Growing!Market! $70! o 2016E!U.S.!Pet!Spend!$63B! $63! $60! $60! $56! $58! • Insensi7ve!to!Recent!Recession!! $53! $48! $51! • 68%!of!U.S.!Households!!!! $50! $43! $46! o 86M!Cats! $41! $39! o 78M!Dogs! $40! $36!

Slide 7: Unmet Medical Need: Canine & Equine Lameness From Osteoarthritis
Unmet!Medical!Need:!Canine!&!Equine!Lameness! From!OsteoarthriRs!(OA)! • OA!is!a!condi7on!with!degenera7ng!car7lage,!crea7ng! joint!s7ffness!from!mechanical!stress!resul7ng!in! inflamma7on!&!pain! • No!current!treatment!for!OA,!only!pallia7ve!pain!therapy! or!joint!replacement! • OA!lameness!worsens!w

Slide 8: Our Solution: Kush Joint Injection for the Treatment of Osteoarthritis
Our!SoluRon:!Kush™!Joint!InjecRon!for!the!Treatment! of!OsteoarthriRs! • Superior!treatment!to!safely!improve!joint!func7on! • Repara7ve!Kush!par7cles!are!lubricious,!cushioning!&!longClas7ng! • These!spongy!proteinCbased!par7cles!mimic!the!composi7on!and! protec7ve!func7on!of!car7lage!(i.e.,!provid

Slide 9: Kush Canine OA Treatment
!!!!Kush!Canine!OA!Treatment! • Kush!Canine!Par7cles!Injected!! Into!Synovial!Space!! • Standard!IntraCAr7cular!Technique!! • No!Special!Training! • Mul7ple!Joints!Can!Be!Treated! Simultaneously! • No!Recovery!Period! • Case!Studies!Show!That!Kush! Canine!Increases!WalkingCRunning! Ac7vity!&!Elimina

Slide 10: Kush Equine Lameness Treatment
!!!Kush!Equine!Lameness!Treatment! • No!Current!Repara7ve!Treatment!for! Equine!Joint!Lameness! • Kush!Equine!Injected!Into!Synovial! Joint!Space!Using!Standard! Technique! • No!Special!Training!Required! • Mul7ple!Joints!Can!Be!Treated! • No!Special!PostCTreatment!! • Case!Studies!Demonstrate!the!!

Slide 11: Initial Kush Markets & Comps
IniRal!Kush!Markets!&!Comps! • Kush!Canine:!Osteoarthri7s!Market!Es7mate!!! • 20,000,000!dogs!with!Osteoarthri7s!(USCEU)! • $2.6B!US(EU!Market!! • Kush!Equine:!Lameness!Market!Es7mate! • 1,000,000!lame!horses!(USCEU)! • $600M!US(EU!Market! • Our!comp!group!consists!of!nine!animal!health!&! pet!thera

Slide 12: Changing Veterinarian Business Model
!!!!Changing!Veterinarian!Business!Model! • Declining!sales!of!high! margin!scripts!that!can!now! Other&Pharma 9% be!filled!at!pharmacies! Annual&Exams& 17% • Vets!looking!for!addi7onal! Vaccinations 15% ways!to!drive!revenue!and! traffic! Diagnostics Flea9Tick&Sales 17% 6% • Kush!can!offer!significantly

Slide 13: Kush vs. Competition
Kush!!vs.!CompeRRon! Hyaluronic!Acid!Joint! Aratana! Treatment! Kush!Canine!(!PetVivo! Rimadyl!(NSAID)! Total!Joint!Replacement! InjecRons! !Galliprant®!(AT(001)! ! ! ! ! ! ! ! ! ! ! ! ! ! Pro! ! Protects!Joint,!Increases! ! Temporary!Pain!Relief! ! Temporary!Pain!Relief! ! Temporary!Pain!Relief! !

Slide 14: Regulatory Environment & Strategy
Regulatory!Environment!&!Strategy!! • No!FDA!PMA!or!510(k)!approval!is!required!for!medical!devices!used!in!veterinary!medicine! • FDA!defines!a!medical!device!as!an!apparatus!or!other!item!that!does!not!achieve!its!intended! purpose!through!chemical!reac7on!in!the!body!and!is!not!dependent!on!being!

Slide 15: Commercialization Strategy & Sales Channels
CommercializaRon!Strategy!&!Sales!Channels! • US!Distribu7on!! o Sales!through!exis7ng!veterinary!distributors!which!account!for!75%!of! U.S.!distribu7on! • MWI,!Paherson!Veterinary,!Butler!Schein!Animal!Health!! o Regional!Business!Development!&!Training!Reps! • Educate!veterinarians!&!clinic!Staff!

Slide 16: Pet & Human Product Pipeline
!Pet!&!Human!Product!Pipeline! ! !Pet!TherapeuRcs!! Species! Safety! Pilot!! Efficacy! Commercial!! VDC01! !OsteoarthriRs! !Canine!(Kush)! !! !! !! !! Q3!2016!! VDC02!! !OsteoarthriRs! !Equine!(Kush)! !! !! !! !! Q4!2016! VDC03!! !Digital!Cushion!Lameness! !Equine!&!Bovine! !! !! !! 2017! VDC04! !Urin

Slide 17: Cost-Efficient Scalable Manufacturing
Cost(Efficient!Scalable!Manufacturing • Validated!Manufacturing!Process! o Manufacturing!FDA!Validated!For!Human!Clinical!Trial! Produc7on!! o SingleCUse!Inline!MFG!Processes! o Very!Scalable!Manufacturing!! o Very!consistent!lotCtoClot!produc7on! o SingleCuse!sterile!nag!processing!eliminate!cleaning

Slide 18: Comprehensive IP Portfolio - Eight Issued US Patents
Comprehensive!IP!Poriolio!(!Eight!Issued!US!Patents! • Eight!US!Patents!with!328!Claims! • Broad!Claim!Language!C!“Comprising”!Transi7ons! • Our!Patents!&!Trade!Secrets!Protect:! • Protein!&!Carbohydrate!Based!Thermoplas7cs! • Biomaterials!of!Many!Composi7ons!! • Medical,!Drug!Delivery!&!Combina7on!

Slide 19: Investment Highlights
Investment!Highlights! • Commercial!stage!pet!therapeu7cs!company! • Ready!to!launch!commercializa7on!of!a!par7culate!device!for!the!$2B! osteoarthri7s!market!in!companion!animals!with!funding! • Kush™!product!offers!significant!benefits!for!the!management!of!pain!over! NSAIDs!which!are!the!exis7ng!sta

Slide 20: PetVivo Holdings, Inc.
PetVivo™!Holdings,!Inc.!! OTCPINK:!PETV! “Running!is!the!Life”! 12100!Singletree!Lane,!Suite!186! Eden!Prairie,!Minnesota! Ph:!612C296C7305! [email protected]! www.petvivo.com!

Slide 21: Appendix A: Technology & Manufacturing
Appendix!A! ! Technology!! &!! Manufacturing! !

Slide 22: Patented BioCoacervation Production Process
Patented!BioCoacerva7on!! Produc7on!Process! Precipita7on! Coacerva7on! Coacervate! Precipita7on!of!Extracellular!Matrix!Components!(Collagen,!!!!!! Elas7n,!Heparin)!into!a!Coacervate!that!is!heat!processed!into! Thermoplas7c!Extracellular!Matrix!(ECM)!Biomaterial!

Slide 23: Matches Natural Precursor Extracellular Matrix
Matches!Natural!Precursor!Extracellular!Matrix!! ! Osmium!Tetroxide!Stained!Samples!Show!Very!Similar!TEM!Micrographs! ! Natural!Precursor!ECM!! MasterGel!! Formed!in!Coronary!Artery!! Biomaterial! During!Stent!Restenosis*! Elas7n! Glycosaminoglycans! *Enhanced!Extracellular!Matrix!Accumulation!in!R

Slide 24: Thermoplastic Properties: Simplified Manufacturing; Many Applications
Thermoplas7c!Proper7es:!Simplified! Manufacturing;!Many!Applica7ons Figure 1A Coated!Catheter! Molded!Gra_! Melted!MasterGel!

Slide 25: Better Implant Material: Why?
Beher!Implant!Material:!Why?!! • Isolated!Purified!Components! o Source!Tissues!Purified!to!Soluble!Component!Form!! o Memory!of!Source!Tissue!Type!Removed!! • Precludes!Wrong!Tissue!Response!e.g.,!Cadaveric!Tissue!! o No!Inflammatory!or!Foreign!Body!Response!! • Comprised!of!Collagen,!Elas7n!&!Heparin

Slide 26: Appendix B: Human Therapeutics
Appendix!B! ! Human!Therapeu7cs!

Slide 27: Leading Human Devices
!Leading!Human!Devices! !!!S ynovoLife™! ORTHOPEDIC!JOINT!TREATMENTS! !!!!D iskLife™! !!!!SPINAL!DISC!TREATMENT! ! CARDIOVASCULAR!DISEASE!TREATMENTS! !UroLife™! TREATMENT!FOR!STRESS!URINARY!INCONTINENCE!

Slide 28: CosmetaLife (Injected Dermal Filler)
CosmetaLife®!(Injected!Dermal!Filler)! • $1.3B!WW!Dermal!Filler!Market! • Growing!Market!10C15%!CAGR! • Successful!150!Pa7ent!Pivotal! Clinical!Trial! o Met!FDA!Primary!Efficacy!Goal!! ParRcles!in!Saline! o No!Different!Than!Restylane!! Inverted!Microscope! o SplitCFace!Nasolabial!Fold! Correc7on! o

Slide 29: Pivotal Clinical Trial Results: Patients Preferred CosmetaLife
Pivotal!Clinical!Trial!Results:!! Pa7ents!Preferred!CosmetaLife™ CosmetaLife!dermal!filler! 100! injected!into!one!side!and! Restylane!(Control)! CosmetaLIfe! injected!into!other!side!of! 80! each!face.!Blinded!Subjects! Restylane! scored!each!nasoClabial! 60! fold!using!the!Global! Aesthe7c!Improvem

Slide 30: Dermal Filler Market & Comps
Dermal!Filler!Market!&!Comps ! • $1.3B!WW!Dermal!Filler!Market1! • 10C15%!CAGR! • Our!comp!group!consists!of!other!dermal!filler! manufactures!and!distributors! o Valeant/Nestle!May!2014!transac7on!($1.4B,!or!more!than! 5.0x!sales)!! o Allergan!trades!at!over!7.0x!2014!E!sales! ! ! ! 1WW!Dermal!Fille

Slide 31: Additional Human Particle Devices & Markets
Addi7onal!Human!Par7cle!Devices!&!Markets! • SynovoLife!–!Synovial!Joint!Injec7on!for!Osteoarthri7s!!! • 6M!(7%)!in!US!Symptoma7c!Knee!Osteoarthri7s!between!age!50!to!84!years(1)! • No!Effec7ve!Repara7ve!Treatment;!Symptom!Treatment!or!Joint!Replacement! • CosmetaLife!–!Lip!Dermal!Filler! • Extension

Slide 32: Cardiovascular Disease Treatments
Cardiovascular!Disease!Treatments! Ovine!Tes7ng!(n=12)!Toxicology! Comparison!Study!to!ePTFE! VasoShunt!–!Arteriovenous!(AV)!Shunt! !!

Slide 33: Cardiovascular Devices & Markets
!Cardiovascular!Devices!&!Markets! • VasoShunt!–!Arteriovenous!(AV)!Shunt! o Annually!≈250,000!US!Dialysis!Pa7ents!Require!Vascular!Access!(US!Renal!Data!System)! o Over!50%!of!Na7ve!&!ePTFE!Shunts!Fail!Within!1!year(1)! • VasoShunt!–!Temporary!Vascular!Shunt!for!Limb!Salvage! o Treatment!of!Vascula

Slide 34: VasoGraft & VasoShunt - Biomaterial Conduit
VasoGra_!&!VasoShunt!–!Biomaterial!Conduit!!!! NonCClong!Ar7ficial!Blood!Vessel • $5.7!M!in!NIH!Grant!Funding! Caro7d! VasoShunt! artery! • Successful!180CDay!Swine!Studies! • Successful!Pilot!Produc7on! • Any!Type!of!Vascular!Gra_!or!Shunt!! • Beher!Than!Gold!Standard!ePTFE!Gra_s! • NonCClong!Prop

Slide 35: VasoShunt: U.S. Dept. of Defense Porcine Clotting Study
!Shunt!–!tube!of!biomaterial VasoShunt:!U.S.!Dept.!of!Defense!Porcine!Clong!Study! • Length!was!5!mm!i.d.!and!5C6!cm!long!(wall!thickness!matches!natural! blood!vessel)! • Able!to!shunt!severed!iliac!artery!for!4–5!hours!without!clong! (hemocompa7ble)!! • 3.8!mm!ID!small!diameter!gra_s!patent!for!
Source: Internet Archive copy of petvivo.com
More decks from PetVivo Holdings Inc
Investor Presentation (October 2026)38 slides · October 2026
Investor Presentation (October 2026)37 slides · October 2026
Investor Presentation (August 2026)36 slides · Aug 20, 2026
Investor Presentation (March 2026)34 slides · March 2026
Investor Presentation (January 2026)32 slides · Jan 22, 2026
Investor Presentation (November 2025)31 slides · Nov 3, 2025